R. Amon, E. M. Reuven, L. Ben-arye, S. Padlerkaravani, and V. , Glycans in immune recognition and response, Carbohydr Res, vol.389, pp.115-122, 2014.

A. Salama, G. Evanno, J. Harb, and J. P. Soulillou, Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation, Xenotransplantation, vol.22, pp.85-94, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02147779

A. Kawanishi, K. Varki, and A. , Human risk of diseases associated with red meat intake: Analysis of current theories and proposed role for metabolic incorporation of a non-human sialic acid, Mol Aspects Med, vol.51, pp.16-30, 2016.

G. Couvrat-desvergnes, A. Salama, L. Berre, L. Evanno, G. Viklicky et al., Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival, J Clin Invest, vol.125, pp.4655-4665, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02147235

J. Heimburg-molinaro, M. Lum, G. Vijay, M. Jain, A. Almogren et al., Cancer vaccines and carbohydrate epitopes, Vaccine, vol.29, pp.8802-8826, 2011.

R. E. Taylor, C. J. Gregg, V. Padler-karavani, D. Ghaderi, H. Yu et al., Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid, J Exp Med, vol.207, pp.1637-1646, 2010.

V. Padler-karavani, A. H. Tremoulet, H. Yu, X. Chen, J. C. Burns et al., A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease, PLoS One, vol.8, p.58443, 2013.

L. Berre, L. Rousse, J. Gourraud, P. A. Imbert-marcille, B. M. Salama et al., Decrease of blood anti-?1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patients, Clin Immunol, vol.180, pp.128-135, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01560209

V. Padler-karavani, H. Yu, H. Cao, H. Chokhawala, F. Karp et al., Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease, Glycobiology, vol.18, pp.818-830, 2008.

L. Scobie, V. Padler-karavani, L. Bas-bernardet, S. Crossan, C. Blaha et al., Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts, J Immunol, vol.191, pp.2907-2915, 2013.

B. Gao, C. Long, W. Lee, Z. Zhang, X. Gao et al., Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans, PLoS One, vol.12, p.180768, 2017.

D. Ghaderi, R. E. Taylor, V. Padler-karavani, S. Diaz, and A. Varki, Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins, Nat Biotechnol. www.impactjournals.com/oncotarget, vol.28, pp.863-867, 2010.

A. N. Samraj, H. Läubli, N. Varki, and A. Varki, Involvement of a non-human sialic Acid in human cancer, Front Oncol, vol.4, p.33, 2014.

A. N. Samraj, O. M. Pearce, H. Läubli, A. N. Crittenden, A. K. Bergfeld et al., A red meat-derived glycan promotes inflammation and cancer progression, Proc Natl Acad Sci U S A, vol.112, pp.542-547, 2015.

A. Varki, R. L. Schnaar, R. Schauer, A. Varki, R. D. Cummings et al., Sialic Acids and Other Nonulosonic Acids, Essentials of Glycobiology. Cold Spring Harbor, 2015.

S. Inoue, C. Sato, and K. Kitajima, Extensive enrichment of N-glycolylneuraminic acid in extracellular sialoglycoproteins abundantly synthesized and secreted by human cancer cells, Glycobiology, vol.20, pp.752-762, 2010.

A. Varki, Colloquium paper: uniquely human evolution of sialic acid genetics and biology, Proc Natl Acad Sci USA, vol.107, pp.8939-8985, 2010.

L. Deng, X. Chen, and A. Varki, Exploration of sialic Acid diversity and biology using sialoglycan microarrays, Biopolymers, vol.99, pp.650-665, 2013.

L. Ben-arye, S. Yu, H. Chen, X. Padler-karavani, and V. , Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay, J Vis Exp, vol.125, p.56094, 2017.

M. Mohty, Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond, Leukemia, vol.21, pp.1387-1394, 2007.

S. E. Gitelman, P. A. Gottlieb, M. R. Rigby, E. I. Felner, S. M. Willi et al., Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial, Lancet Diabetes Endocrinol, vol.1, pp.306-316, 2013.

S. E. Gitelman, P. A. Gottlieb, E. I. Felner, S. M. Willi, L. K. Fisher et al., and ITN START Study Team. Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial, Diabetologia, vol.59, pp.1153-1161, 2016.

A. Salama, G. Evanno, N. Lim, J. Rousse, L. Berre et al., Anti-Gal and Anti-Neu5Gc Responses in Nonimmunosuppressed Patients After Treatment With Rabbit Antithymocyte Polyclonal IgGs, Transplantation, vol.101, pp.2501-2507, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02156016

M. S. Zand, T. Vo, J. Huggins, R. Felgar, J. Liesveld et al., Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways, Transplantation, vol.79, pp.1507-1515, 2005.

L. M. Corcoran and D. M. Tarlinton, Regulation of germinal center responses, memory B cells and plasma cell formation-an update, Curr Opin Immunol, vol.39, pp.59-67, 2016.

O. Leavy, Immune memory: Sequential evolution of B cell memory, Nat Rev Immunol, vol.16, pp.72-73, 2016.

S. Kavaler, H. Morinaga, A. Jih, W. Fan, M. Hedlund et al., Pancreatic beta-cell failure in obese mice with human-like CMP-Neu5Ac hydroxylase deficiency, FASEB J, vol.25, pp.1887-1893, 2011.

M. Hedlund, V. Padler-karavani, N. M. Varki, and A. Varki, Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression, Proc Natl Acad Sci, vol.105, pp.18936-18941, 2008.

V. Padler-karavani, N. Hurtado-ziola, M. Pu, H. Yu, S. Huang et al., Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer, Cancer Res, vol.71, pp.3352-3363, 2011.

O. M. Pearce, H. Laubli, A. Verhagen, P. Secrest, J. Zhang et al., Inverse hormesis of cancer growth mediated by narrow ranges of tumordirected antibodies, Proc Natl Acad Sci, vol.111, pp.5998-6003, 2014.

T. Pham, C. J. Gregg, F. Karp, R. Chow, V. Padler-karavani et al., Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium, Blood, vol.114, pp.5225-5235, 2009.

J. Okerblom, A. Varki, and . Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid, ChemBioChem, vol.18, pp.1155-71, 2017.

V. Padler-karavani, X. Song, H. Yu, N. Hurtado-ziola, S. Huang et al., Cross-comparison of protein recognition of sialic acid diversity on two novel sialoglycan microarrays, J Biol Chem, vol.287, pp.22593-22608, 2012.